4//SEC Filing
Crystal Adam 4
Accession 0000950170-25-015693
CIK 0001819133other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:08 PM ET
Size
7.3 KB
Accession
0000950170-25-015693
Insider Transaction Report
Form 4
Crystal Adam
See Remarks
Transactions
- Sale
Common Stock
2025-02-04$2.99/sh−7,432$22,207→ 165,061 total - Sale
Common Stock
2025-02-05$3.16/sh−6,851$21,659→ 158,210 total
Footnotes (3)
- [F1]The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001825445
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:08 PM ET
- Size
- 7.3 KB